13 LeungAMBravermanLEPearceEN
Using a 1:1 propensity score matching (PSM) model, we matched patients of both cohorts based on baseline demographics, comorbidities (hypertensive disorders, ischemic heart disease, gallstones, annular pancreas, alcohol use disorders, hypertriglyceridemia, hypercalcemia, cystic fibrosis, and cannabis use), medications known to cause drug-related pancreatitis, and laboratory values
Polysomnography (PSG) remains the cornerstone for comprehensive sleep assessment, providing detailed insights into sleep stages, respiratory parameters, and neurological activity
Brain TACE (Tumor Necrosis Factor-Converting Enzyme) contributes to sympathetic excitation in heart failure rats
Asked whether hed consider investing in areas such as skincare, hair loss and other appearance-related conditions that have become increasingly intertwined with the rise of weight-loss drugs, Doustdar was quick to answer: Yes. Rather than citing a specific scientific breakthrough, he framed the opportunity as an extension of Novos longstanding strategy of responding to market needs for improved patient outcomes
